Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life Setting

PURPOSE: To assess real-life efficacy of ranibizumab and treatment compliance of patients with vision loss secondary to diabetic macular edema (DME). METHODS: A retrospective study was conducted in DME patients treated with ranibizumab. Patients were monitored every 4 weeks for visual acuity (VA) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Best, Anne-Laurence, Fajnkuchen, Franck, Nghiem-Buffet, Sylvia, Grenet, Typhaine, Quentel, Gabriel, Delahaye-Mazza, Corinne, Cohen, Salomon Y., Giocanti-Aurégan, Audrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932481/
https://www.ncbi.nlm.nih.gov/pubmed/29850205
http://dx.doi.org/10.1155/2018/4610129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932481/
https://www.ncbi.nlm.nih.gov/pubmed/29850205
http://dx.doi.org/10.1155/2018/4610129

Ejemplares similares